AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $162,000 | +39.7% | 12,239 | +151.6% | 0.00% | 0.0% |
| Q2 2016 | $116,000 | +16.0% | 4,864 | +13.8% | 0.00% | 0.0% |
| Q1 2016 | $100,000 | +3.1% | 4,275 | +33.6% | 0.00% | 0.0% |
| Q4 2015 | $97,000 | -41.6% | 3,201 | -23.4% | 0.00% | 0.0% |
| Q3 2015 | $166,000 | +137.1% | 4,177 | +312.3% | 0.00% | 0.0% |
| Q2 2015 | $70,000 | -82.6% | 1,013 | -86.3% | 0.00% | -66.7% |
| Q1 2015 | $403,000 | +1579.2% | 7,375 | +1212.3% | 0.00% | – |
| Q4 2014 | $24,000 | +14.3% | 562 | -15.6% | 0.00% | – |
| Q3 2014 | $21,000 | +75.0% | 666 | +10.6% | 0.00% | – |
| Q2 2014 | $12,000 | 0.0% | 602 | 0.0% | 0.00% | – |
| Q1 2014 | $12,000 | -20.0% | 602 | -0.8% | 0.00% | – |
| Q4 2013 | $15,000 | -65.1% | 607 | -69.7% | 0.00% | – |
| Q3 2013 | $43,000 | +79.2% | 2,002 | +81.8% | 0.00% | – |
| Q2 2013 | $24,000 | – | 1,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |